SA
TMO icon

Sovran Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Sovran Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Buy
457
+5
+1% +$2.4K 0.02% 517
2026
Q1 		$217K Buy
452
+42
+10% +$22.8K 0.02% 540
2025
Q4 		$256K Buy
410
+10
+3% +$5.66K 0.02% 479
2025
Q3 		$222K Buy
+400
New +$186K 0.02% 487

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sovran Advisors's TMO Position: Q2 2026 in Review

Sovran Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, buying an estimated $2.4K and bringing the position to 457 shares worth $263K. The position accounts for 0.02% of the portfolio, ranked #517.

Sovran Advisors first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sovran Advisors held 457 shares of Thermo Fisher Scientific worth $263K as of Q2 2026.
  • Sovran Advisors bought 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.02% of Sovran Advisors's portfolio in Q2 2026, its #517 holding.
  • Sovran Advisors first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.